Company Filing History:
Years Active: 2005-2024
Title: Innovations and Contributions of John R Barta
Introduction
John R Barta is a notable inventor based in Guelph, Canada, recognized for his significant contributions to the field of immunology. With a total of 10 patents to his name, Barta has made strides in developing vaccine vectors aimed at enhancing immune responses and limiting infections.
Latest Patents
Among his latest patents, Barta has developed compositions and methods for enhancing immune responses to Apicomplexan parasites. His work includes vaccine vectors that incorporate a polynucleotide encoding a Rhomboid polypeptide, which may also feature an immune-stimulatory polypeptide expressed on the surface of the vaccine vector. Additionally, he has focused on methods to enhance immune responses to Eimeria, further contributing to the fight against parasitic infections.
Career Highlights
Barta has had a distinguished career, working with esteemed institutions such as the University of Arkansas and Texas A&M University System. His research has been pivotal in advancing the understanding of immune responses and developing innovative solutions to combat infections.
Collaborations
Throughout his career, Barta has collaborated with notable colleagues, including Billy M Hargis and Luc Berghman. These partnerships have enriched his research and contributed to the success of his innovative projects.
Conclusion
John R Barta's work exemplifies the impact of innovation in the field of immunology. His patents and research continue to pave the way for advancements in vaccine development and infectious disease management.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.